ICU fluid overload: could cutting salt save lives?
NCT ID NCT07189091
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether using lower-salt intravenous fluids in ICU patients reduces the number of days they need life support like ventilators or dialysis. Researchers will compare a salt-free glucose solution for medication dilution and a low-salt maintenance fluid against the usual higher-salt fluids. The trial enrolls 640 critically ill adults expected to stay in the ICU for several days.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- lower-salt intravenous fluids (glucose 5% and NaCl 0.3% in glucose 3.3%)
- What this could lead to
- If it works, this could lead to a simple change in ICU fluid practices that helps patients recover faster and spend fewer days on life support.
- What could go wrong
- This is a single-center trial, so results may not apply everywhere. The benefit may be small or none, and lower-salt fluids could cause electrolyte imbalances in some patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 4
Runs after approval, following long-term safety and how well the treatment works in everyday use.
- Participants
-
About 640 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Oct 2025
- Expected to finish
-
Jul 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion criteria 1. At least 18 years of age 2. Patients who are admitted to the ICU for medical or surgical emergencies, including complications of elective surgery 3. The treating physician expects the patient will still require ICU care in two days, indicating a severe or complex condition at enrollment 4. The patient is expected to receive at least 300 mL of fluid creep or at least 1 liter of maintenance fluid according to study-arm during the first 24h after inclusion Exclusion Criteria: 1. A contraindication to hypotonic fluids due to risk of brain edema (including traumatic brain injury, major stroke, intracranial/subarachnoid hemorrhage, meningoencephalitis, intracranial malignancies…), with the timing and clinical judgment left at the discretion of the treating physician. 2. Hyponatremia below 131 mmol/L at admission 3. Admission solely for treatment of fluid accumulation due to cardiac decompensation, without other acute medical conditions requiring ICU-level care. Note: Patients with heart failure as a comorbidity, those on chronic diuretic therapy, or presenting with edema/bilateral lung infiltrates due to other conditions (e.g., sepsis, pneumonia) are not excluded. 4. Patient's death is deemed imminent and inevitable, admission for palliative care or admission solely for organ donation 5. Patient receiving chronic renal replacement therapy 6. Patients referred after a stay of more than 24 hours in another ICU 7. Patients randomized in CRUSADERS before 8. Patient is co-enrolled in an unapproved concomitant ICU-trial or in any trial with an intervention that affects fluid administration or fluid balance Additional exclusion criteria for the SALADIN nested substudy 1. Patients expected to require renal replacement therapy within 24 hours 2. Increased insensible fluid losses: burns, extensive wounds or skin defects or massive diarrhea,… 3. Patients without a urine catheter 4. Patients expected to require bladder irrigation within 24 hours 5. Patients on chronic treatment with loop or thiazide diuretics (including combination preparations)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Critical care, intensive care are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
4 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Antwerp University Hopsital (UZA)
NOT_YET_RECRUITINGEdegem, 2650, Belgium
-
ZAS Cadix
RECRUITINGAntwerp, 2030, Belgium
-
ZAS Middelheim
NOT_YET_RECRUITINGAntwerp, 2020, Belgium
-
ZAS Paflijn
NOT_YET_RECRUITINGMerksem, 2170, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Why do some ICU patients bleed in the gut? researchers map the risk
- Hidden pressure: how continuous kidney dialysis may affect the abdomen in ICU patients
- Do antibiotics reach the battlefield? muscle probe tests drug delivery in sick kids
- Do ICU family meetings for the very old vary across europe?
- COVID-19's hidden toll: muscle wasting in the ICU
- Can protein and pedaling save ICU Patients' muscles?